{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:25:30Z","timestamp":1791919530316,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100011681","name":"R\u00e4ttsmedicinalverket","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003945","name":"Link\u00f6ping University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003945","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s13318-021-00750-9","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T10:03:18Z","timestamp":1642068198000},"page":"259-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oxycodone-Related Deaths: The Significance of Pharmacokinetic and Pharmacodynamic Drug Interactions"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3249-3351","authenticated-orcid":false,"given":"Gerd","family":"Jakobsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7469-5851","authenticated-orcid":false,"given":"Sara","family":"Gustavsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0361-162X","authenticated-orcid":false,"given":"Anna K.","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-0056","authenticated-orcid":false,"given":"Johan","family":"Ahlner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-5728","authenticated-orcid":false,"given":"Henrik","family":"Gr\u00e9en","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4222-9597","authenticated-orcid":false,"given":"Robert","family":"Kronstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"issue":"3","key":"750_CR1","doi-asserted-by":"publisher","first-page":"e599","DOI":"10.1097\/PR9.0000000000000599","volume":"2","author":"W Hauser","year":"2017","unstructured":"Hauser W, Schug S, Furlan AD. The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents. Pain Rep. 2017;2(3):e599. https:\/\/doi.org\/10.1097\/PR9.0000000000000599.","journal-title":"Pain Rep."},{"issue":"3","key":"750_CR2","doi-asserted-by":"publisher","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","volume":"15","author":"L Manchikanti","year":"2012","unstructured":"Manchikanti L, Helm S 2nd, Fellows B, Janata JW, et al. Opioid epidemic in the United States. Pain Physician. 2012;15(3):ES9-38.","journal-title":"Pain Physician"},{"key":"750_CR3","doi-asserted-by":"publisher","unstructured":"Pilgrim, J. L., Yafistham, S. P., Gaya, S., Saar, E., et al. An update on oxycodone: lessons for death investigators in Australia. Forensic Sci Med Pathol. 2015. 11;1):3-12. https:\/\/doi.org\/10.1007\/s12024-014-9624-x.","DOI":"10.1007\/s12024-014-9624-x"},{"issue":"1","key":"750_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40122-018-0096-7","volume":"7","author":"EA Shipton","year":"2018","unstructured":"Shipton EA, Shipton EE, Shipton AJ. A review of the opioid epidemic: what do we do about it? Pain Ther. 2018;7(1):23\u201336. https:\/\/doi.org\/10.1007\/s40122-018-0096-7.","journal-title":"Pain Ther"},{"issue":"1","key":"750_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/FTD.0000000000000789","volume":"43","author":"J van Amsterdam","year":"2021","unstructured":"van Amsterdam J, Pierce M, van den Brink W. Is Europe facing an emerging opioid crisis comparable to the U.S.? Ther Drug Monit. 2021;43(1):42\u201351. https:\/\/doi.org\/10.1097\/FTD.0000000000000789.","journal-title":"Ther Drug Monit"},{"key":"750_CR6","unstructured":"Backryd E, Heilig M, Hoffmann M. Opioid prescription changes in Sweden 2000\u20132015. Lakartidningen. 2017. p. 114. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28485763"},{"issue":"2","key":"750_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1515\/sjpain-2018-0307","volume":"19","author":"AE Muller","year":"2019","unstructured":"Muller AE, Clausen T, Sjogren P, Odsbu I, et al. Prescribed opioid analgesic use developments in three Nordic countries, 2006\u20132017. Scand J Pain. 2019;19(2):345\u201353. https:\/\/doi.org\/10.1515\/sjpain-2018-0307.","journal-title":"Scand J Pain"},{"key":"750_CR8","unstructured":"Centers for Disease Control and Prevention (CDC). https:\/\/www.cdc.gov\/drugoverdose\/data\/prescribing\/overdose-death-maps.html. Accessed 13 July 2021."},{"issue":"1","key":"750_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/pme.12907","volume":"17","author":"N Dasgupta","year":"2016","unstructured":"Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, et al. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med. 2016;17(1):85\u201398. https:\/\/doi.org\/10.1111\/pme.12907.","journal-title":"Pain Med"},{"issue":"1\u20133","key":"750_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.forsciint.2012.07.016","volume":"223","author":"A Ogle","year":"2012","unstructured":"Ogle A, Moore K, Barrett B, Young MS, et al. Clinical history and characteristics of persons with oxycodone-related deaths in Hillsborough County, Florida in 2009. Forensic Sci Int. 2012;223(1\u20133):47\u201352. https:\/\/doi.org\/10.1016\/j.forsciint.2012.07.016.","journal-title":"Forensic Sci Int"},{"issue":"6","key":"750_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s40262-018-00731-3","volume":"58","author":"M Kinnunen","year":"2019","unstructured":"Kinnunen M, Piirainen P, Kokki H, Lammi P, et al. Updated clinical pharmacokinetics and pharmacodynamics of oxycodone. Clin Pharmacokinet. 2019;58(6):705\u201325. https:\/\/doi.org\/10.1007\/s40262-018-00731-3.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"750_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/jcpt.13113","volume":"45","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kim JY, Lee N, Yee J, et al. The impact of drug interactions on adverse effects of oral oxycodone in male geriatric patients. J Clin Pharm Ther. 2020;45(5):976\u201382. https:\/\/doi.org\/10.1111\/jcpt.13113.","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"750_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40268-019-00282-3","volume":"19","author":"B Ji","year":"2019","unstructured":"Ji B, Liu S, Xue Y, He X, et al. Prediction of drug-drug interactions between opioids and overdosed benzodiazepines using physiologically based pharmacokinetic (PBPK) modeling and simulation. Drugs R D. 2019;19(3):297\u2013305. https:\/\/doi.org\/10.1007\/s40268-019-00282-3.","journal-title":"Drugs R D."},{"key":"750_CR14","doi-asserted-by":"publisher","first-page":"108854","DOI":"10.1016\/j.drugalcdep.2021.108854","volume":"225","author":"MJ Bannon","year":"2021","unstructured":"Bannon MJ, Lapansie AR, Jaster AM, Saad MH, et al. Opioid deaths involving concurrent benzodiazepine use: assessing risk factors through the analysis of prescription drug monitoring data and postmortem toxicology. Drug Alcohol Depend. 2021;225:108854. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108854.","journal-title":"Drug Alcohol Depend"},{"key":"750_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2314","author":"NF Khan","year":"2021","unstructured":"Khan NF, Bykov K, Glynn RJ, Barnett ML, et al. Coprescription of opioids with other medications and risk of opioid overdose. Clin Pharmacol Ther. 2021. https:\/\/doi.org\/10.1002\/cpt.2314.","journal-title":"Clin Pharmacol Ther"},{"key":"750_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","volume":"200","author":"VR Votaw","year":"2019","unstructured":"Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: a systematic review. Drug Alcohol Depend. 2019;200:95\u2013114. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.02.033.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"750_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","volume":"51","author":"CS Hwang","year":"2016","unstructured":"Hwang CS, Kang EM, Kornegay CJ, Staffa JA, et al. Trends in the concomitant prescribing of opioids and benzodiazepines, 2002\u20132014. Am J Prev Med. 2016;51(2):151\u201360. https:\/\/doi.org\/10.1016\/j.amepre.2016.02.014.","journal-title":"Am J Prev Med"},{"issue":"1","key":"750_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5694\/mja2.12026","volume":"210","author":"GE Caughey","year":"2019","unstructured":"Caughey GE, Gadzhanova S, Shakib S, Roughead EE. Concomitant prescribing of opioids and benzodiazepines in Australia, 2012\u20132017. Med J Aust. 2019;210(1):39\u201340. https:\/\/doi.org\/10.5694\/mja2.12026.","journal-title":"Med J Aust"},{"key":"750_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/add.15211","author":"AB Bech","year":"2020","unstructured":"Bech AB, Clausen T, Waal H, Vindenes V, et al. Post-mortem toxicological analyses of blood samples from 107 patients receiving opioid agonist treatment: substances detected and pooled opioid and benzodiazepine concentrations. Addiction. 2020. https:\/\/doi.org\/10.1111\/add.15211.","journal-title":"Addiction"},{"issue":"10","key":"750_CR20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jpain.2018.04.013","volume":"19","author":"KE Vowles","year":"2018","unstructured":"Vowles KE, Witkiewitz K, Pielech M, Edwards KA, et al. Alcohol and opioid use in chronic pain: a cross-sectional examination of differences in functioning based on misuse status. J Pain. 2018;19(10):1181\u20138. https:\/\/doi.org\/10.1016\/j.jpain.2018.04.013.","journal-title":"J Pain"},{"issue":"3","key":"750_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00228-011-1122-4","volume":"68","author":"M Hakkinen","year":"2012","unstructured":"Hakkinen M, Launiainen T, Vuori E, Ojanpera I. Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning. Eur J Clin Pharmacol. 2012;68(3):301\u20139. https:\/\/doi.org\/10.1007\/s00228-011-1122-4.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"750_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/00365521.2016.1246605","volume":"52","author":"GL Jakobsson","year":"2017","unstructured":"Jakobsson GL, Sternegard E, Olen O, Myrelid P, et al. Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG). Scand J Gastroenterol. 2017;52(2):216\u201321. https:\/\/doi.org\/10.1080\/00365521.2016.1246605.","journal-title":"Scand J Gastroenterol"},{"key":"750_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. https:\/\/doi.org\/10.1186\/1471-2458-11-450.","journal-title":"BMC Public Health"},{"issue":"7","key":"750_CR24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, et al. The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335. https:\/\/doi.org\/10.1002\/pds.1294.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"750_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","volume":"24","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659\u201367. https:\/\/doi.org\/10.1007\/s10654-009-9350-y.","journal-title":"Eur J Epidemiol"},{"key":"750_CR26","unstructured":"World Health Organization (WHO). https:\/\/www.euro.who.int\/en\/health-topics\/disease-prevention\/nutrition\/a-healthy-lifestyle\/body-mass-index-bmi. Accessed 24 Sept 2021."},{"key":"750_CR27","unstructured":"2021.https:\/\/janusmed.sll.se\/interaktioner\/substance\/oxikodon. Accessed 7 Jan 2021."},{"issue":"1\u20132","key":"750_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","volume":"125","author":"JD Jones","year":"2012","unstructured":"Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1\u20132):8\u201318. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.07.004.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"750_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/ADM.0000000000000513","volume":"13","author":"C Griggs","year":"2019","unstructured":"Griggs C, Wyatt S, Wally MK, Runyon M, et al. Prescribing of opioids and benzodiazepines among patients with history of overdose. J Addict Med. 2019;13(5):396\u2013402. https:\/\/doi.org\/10.1097\/ADM.0000000000000513.","journal-title":"J Addict Med"},{"issue":"4","key":"750_CR30","doi-asserted-by":"publisher","first-page":"e202361","DOI":"10.1001\/jamanetworkopen.2020.2361","volume":"3","author":"ME Tori","year":"2020","unstructured":"Tori ME, Larochelle MR, Naimi TS. Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999\u20132017. JAMA Netw Open. 2020;3(4):e202361. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2361.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"750_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/add.14014","volume":"113","author":"J Haukka","year":"2018","unstructured":"Haukka J, Kriikku P, Mariottini C, Partonen T, et al. Non-medical use of psychoactive prescription drugs is associated with fatal poisoning. Addiction. 2018;113(3):464\u201372. https:\/\/doi.org\/10.1111\/add.14014.","journal-title":"Addiction"},{"key":"750_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.forsciint.2014.01.005","volume":"236","author":"AK Jonsson","year":"2014","unstructured":"Jonsson AK, Soderberg C, Espnes KA, Ahlner J, et al. Sedative and hypnotic drugs\u2013fatal and non-fatal reference blood concentrations. Forensic Sci Int. 2014;236:138\u201345. https:\/\/doi.org\/10.1016\/j.forsciint.2014.01.005.","journal-title":"Forensic Sci Int"},{"issue":"9","key":"750_CR33","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/dta.2662","volume":"11","author":"RA Ketola","year":"2019","unstructured":"Ketola RA, Kriikku P. Drug concentrations in post-mortem specimens. Drug Test Anal. 2019;11(9):1338\u201357. https:\/\/doi.org\/10.1002\/dta.2662.","journal-title":"Drug Test Anal"},{"issue":"4","key":"750_CR34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/dta.1507","volume":"6","author":"T Launiainen","year":"2014","unstructured":"Launiainen T, Ojanpera I. Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma. Drug Test Anal. 2014;6(4):308\u201316. https:\/\/doi.org\/10.1002\/dta.1507.","journal-title":"Drug Test Anal"},{"key":"750_CR35","doi-asserted-by":"publisher","first-page":"110883","DOI":"10.1016\/j.forsciint.2021.110883","volume":"325","author":"E Lefrancois","year":"2021","unstructured":"Lefrancois E, Reymond N, Thomas A, Lardi C, et al. Summary statistics for drugs and alcohol concentration recovered in post-mortem femoral blood in Western Switzerland. Forensic Sci Int. 2021;325:110883. https:\/\/doi.org\/10.1016\/j.forsciint.2021.110883.","journal-title":"Forensic Sci Int"},{"key":"750_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.forsciint.2016.05.002","volume":"266","author":"C Soderberg","year":"2016","unstructured":"Soderberg C, Wernvik E, Tillmar A, Spigset O, et al. Antipsychotics\u2014postmortem fatal and non-fatal reference concentrations. Forensic Sci Int. 2016;266:91\u2013101. https:\/\/doi.org\/10.1016\/j.forsciint.2016.05.002.","journal-title":"Forensic Sci Int"},{"issue":"2","key":"750_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/jat\/32.2.165","volume":"32","author":"DD Baker","year":"2008","unstructured":"Baker DD, Jenkins AJ. A comparison of methadone, oxycodone, and hydrocodone related deaths in Northeast Ohio. J Anal Toxicol. 2008;32(2):165\u201371. https:\/\/doi.org\/10.1093\/jat\/32.2.165.","journal-title":"J Anal Toxicol"},{"issue":"7","key":"750_CR38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/jat\/28.7.616","volume":"28","author":"EJ Cone","year":"2004","unstructured":"Cone EJ, Fant RV, Rohay JM, Caplan YH, et al. Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions. J Anal Toxicol. 2004;28(7):616\u201324. https:\/\/doi.org\/10.1093\/jat\/28.7.616.","journal-title":"J Anal Toxicol"},{"issue":"2","key":"750_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/jat\/bkaa051","volume":"45","author":"G Jakobsson","year":"2021","unstructured":"Jakobsson G, Green H, Kronstrand R. Oxycodone concentrations and metabolic ratios in femoral blood from fatal intoxications and other causes of death using LC-MS-MS. J Anal Toxicol. 2021;45(2):124\u201333. https:\/\/doi.org\/10.1093\/jat\/bkaa051.","journal-title":"J Anal Toxicol"},{"key":"750_CR40","doi-asserted-by":"publisher","first-page":"110292","DOI":"10.1016\/j.forsciint.2020.110292","volume":"311","author":"C Soderberg","year":"2020","unstructured":"Soderberg C, Tillmar A, Johansson A, Wernvik E, et al. The importance of sample size with regard to the robustness of postmortem reference values. Forensic Sci Int. 2020;311:110292. https:\/\/doi.org\/10.1016\/j.forsciint.2020.110292.","journal-title":"Forensic Sci Int"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00750-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-021-00750-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00750-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T02:10:08Z","timestamp":1647051008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-021-00750-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["750"],"URL":"https:\/\/doi.org\/10.1007\/s13318-021-00750-9","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"15 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was funded by the National Board of Forensic Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Data are available on request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AKJ and JA conceived a general design and applied for ethical approval. AKJ, GJ, HG, JK, and RK conceptualized the research questions and designed the study. SG and AKJ coordinated the retrieval of data from registers. SG, AKJ and HG supervised the statistical analyses and GJ and RK curated and analyzed the data and wrote the draft manuscript. All authors contributed to the manuscript and approved the final version.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The study was approved by the Regional Ethics Review Board in Link\u00f6ping, Sweden, No. 2016\/489-31 including extension 2018\/577-32.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}